|Base Year Market Size
|USD 1.04 Billion
|Forecast Year Market Size
|USD 1.56 Billion
|Fastest Growing Market
The global sugar based excipients market size was valued at USD 1.04 billion in 2022. It is projected to reach USD 1.56 billion by 2031, growing at a CAGR of 4.6 % during the forecast period (2023–2031).
Sugar Based Excipients are inactive ingredients used in drugs to support the active ingredient, bulk the solid formulation, and maintain stability. Gum, syrups, starch, and others are excipients. This reduces viscosity and improves solubility. Excipients give medicine taste, color, and texture. Pure sugar, polymer, complex starches, and even human and gelatin are excipients. Sugar-based excipients are pharmaceutical fillers, tonicity modifiers, diluents, and sweeteners. Mannitol, an expensive sugar based excipient, refreshes chewable tablets like lozenges. The sugar alcohol industry is benefiting from Mannitol's wide range of dosages. Granular, powder, crystal, and syrup sugar-based excipients market are available. Sugar Based Excipients may contain harmful impurities. Impurities can cause dangerous immune responses in patients. Oral prescription drugs use sugar based excipients most often. It is mainly considered for test-biter medications coordinated with the active ingredient. Glycerol, saccharin sodium, sucrose, and sorbitol are sugar-based excipients. Antibiotics and syrups mostly use sugar-based excipients. Pharmaceutical excipients deliver drugs. New drugs and pharmaceutical advances are expanding the sugar excipients market. Increasing demand for generic drugs, nanotechnology to improve API stability, and improved healthcare infrastructure drive market growth.
Orally disintegrating tablets and their development are growing the market. Orally disintegrating tablets dissolve on the tongue, unlike traditional tablets. Orally disintegrating tablets are in demand as geriatric and pediatric patients rise. According to the August 2022 study "Orally Dispersible Dosage Forms for Pediatric Use: Current Knowledge and Development of Nanostructure Based Formulations," saccharides and sugar alcohols have long been interested in orodispersible formulations due to their high-water solubility and taste-improving properties. Thus, several Orally Dispersible Dosage Forms (ODx) excipient combinations contain monosaccharides and their alcohols. Sugars or sugar alcohols and other excipients ensure tablet uniformity and structure. Thus, sugar based excipients in orally dispersible tablets should increase in demand due to their benefits.
Sugar based excipient manufacturing has strict guidelines. Since sugar is used daily, eating it can cause diseases. This industry is challenged by strict quality control and price pressures from significant players. Quality control reduces manufacturing sites for this industry. Manufacturers have little margin due to product quality. Manufacturers face price pressure. FDA guidance requires risk management plans for rare disease drugs, drugs without "appropriate alternatives," and public health emergency countermeasures.
The generic market's rapid growth is fueling this sector. The company is optimizing drug formulation and delivery excipients. They also develop formulations. These factors will likely shape product development and commercialization. Sugar based excipients are used in oral drug manufacturing, pharmaceutical innovation, and manufacturing, and government agencies are investing in research to develop more innovative products. Sugar based pharmaceutical excipients are safer, and most patients of all ages like sweet tests. Sugar based excipients cover bite flavors with market potential. The FDA requires generic drugs to have the same active ingredient, dosage, strength, safety, use conditions, and administration route as brand-name drugs. The absorption rate and extent of the generic drug are bioequivalent to the branded product.
The global sugar based excipients market is bifurcated into four regions: North America, Europe, Asia-Pacific, and LAMEA.
Europe is the most significant shareholder in the global sugar based excipients market and is expected to grow at a CAGR of 4.14% during the forecast period. The UK, Germany, France, Italy, Spain, and the rest of Europe are all included in the analysis of Europe's sugar based excipients market. Innovative drug investments and generic drug demand are to blame. Pharma growth is shaping Europe's economy. The European Federation of Pharmaceutical Industries and Associations reported USD 39,440 million in European R&D. Drug companies have always valued Europe. Pharma companies can benefit from their growing population and favorable health policies. Europe's sugar excipients market is forecast to proliferate. Big pharmaceutical companies and their use of innovative medical technologies to improve treatment drive revenue in the region. Geriatric and pediatric patients increase market growth in this region. Drug development investments and favorable regional government policies are driving the market. Major pharmaceutical companies and advanced medical technology to improve treatments are responsible for most of it. Oral medication excipients are mostly sugar based. Pediatric medications are prioritized. Sucrose, glycerol, sodium saccharin, sorbitol, antibiotics, and children's cough syrup use it. Elderly and pediatric patients will also boost the market growth. Drug development investment, generic drug production, and regional government initiatives also drove market growth.
Asia Pacific is expected to grow at the fastest CAGR of 5.2% during the forecast period. China, India, Japan, Australia, and the rest of Asia-Pacific are all included in the analysis of the Asia-Pacific sugar-based excipients market. Due to its growing pharma industry and sugar excipients research and development, Asia Pacific is expected to account for a significant revenue share. Asia-Pacific is growing at the fastest rate due to favorable healthcare policies by governments and increasing significant base and capabilities. Eastern and Western Europe dominate the sugar based excipient market due to government policies that encourage drug development and generic drug production. Low manufacturing costs in developing countries like China, India, and Korea and growth policies in the medical and pharmaceutical industries are expected to benefit the Asia-Pacific region, excluding Japan and the sugar based excipient market.
|Archer Daniels Midland Company Meggle AG Ashland Inc. The Lubrizol Corporation Roquette Group DFE Pharma Cargill, Inc. Associated British Foods PLC Colorcon Inc. and FMC Corporation BASF SE MB Sugars & Pharmaceuticals Citron Scientific Harshad Agencies Emilio Castelli New Zealand Pharmaceuticals Limited IMCD Pharma Pfanstiehl, Inc.
|U.K. Germany France Spain Italy Russia Nordic Benelux Rest of Europe
|China Korea Japan India Australia Taiwan South East Asia Rest of Asia-Pacific
|Middle East and Africa
|UAE Turkey Saudi Arabia South Africa Egypt Nigeria Rest of MEA
|Brazil Mexico Argentina Chile Colombia Rest of LATAM
|Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
The market is segmented by product, type, application, and formulation.
Based on the product, the global sugar based excipients market is bifurcated into actual sugar, artificial sweeteners, and sugar alcohol.
The actual sugar segment is the highest contributor to the market and is expected to grow at a CAGR of 4.28% during the forecast period. Over the forecast period, actual sugar will generate the most market revenue. Its non-toxicity and low medication interaction make it prevalent in oral and pediatric formulations, accounting for a significant market share. Sugar is an essential food ingredient. Sugar balances acidity, adds bulk, and prevents spoilage in addition to sweetness. Did you know sugar is used to make medication, bioplastics for planes, and flower preservatives? Sugar has many non-food uses.
Based on type, the global sugar based excipients market is bifurcated into crystals, powders, compression sugars, and syrups.
The powders segment is the highest contributor to the market and is expected to grow at a CAGR of 4.56% during the forecast period. Different crystal sizes give sugars unique functional properties that make them suitable for different foods and beverages: molasses’ flavor and moisture change sugar color. The sugar caramelizes when heated. Some sugars are only used in food. Sugars are the most straightforward carbohydrates—mono- and disaccharides. Monosaccharides include glucose, galactose, and fructose; disaccharides include sucrose, lactose, maltose, and trehalose. Sugars can be found in fruits, vegetables, dairy products, and nuts; extracted from plants and dairy and added to foods; or made from plant or dairy ingredients.
Based on application, the global sugar based excipients market is bifurcated into diluents, fillers, tonicity agents, and flavoring agents.
The flavoring agent segment is the highest contributor to the market and is expected to grow at a CAGR of 4.72% during the forecast period. Fruit, nuts, seafood, spice blends, vegetables, and wine are natural flavoring agents. Chemical flavors mimic natural flavors. Alcohols are bitter and medicinal, esters are fruity, ketones and pyrazines flavor caramel, phenolics are smokey, and terpenoids are citrus or pine-flavored. Sugar is widely used. Like iodine and lipids, amylose forms an inclusion complex within its helical structure to bind. Some flavor molecules may become physically entrapped by starch polymer chains, but these molecules are unlikely to be retained during storage.
Based on formulation, the global sugar based excipients market is bifurcated into oral, parenteral, and topical.
The oral segment is the highest contributor to the market and is expected to grow at a CAGR of 4.5% during the forecast period. ODTs are a popular alternative to tablets and capsules. ODTs dissolve in the mouth without water in 60 seconds or less. When placed on the tongue, a solid dosage form containing medicinal substances disintegrates quickly, usually within seconds, according to the US FDA Center for Drug Evaluation and Research (CDER) Orange Book. The European Pharmacopoeia defines orodisperse as a tablet that dissolves quickly in the mouth before swallowing.